|7. Treat with an IL-17i biologic over an IL-12/23i biologic (PICO 15)|Very low|
|Conditional recommendation based on very-low-quality evidence; may consider an IL-12/23i biologic if the patient has concomitant IBD or prefers less frequent drug administration.| |</p>